Re: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment

Moe Tsuda¹, Hiroshi Ishiguro², Ikuko Yano¹, Masakazu Toi¹

Affiliations

¹ Affiliation of authors: Department of Breast Surgery (MTs, MTo) and Outpatient Oncology Unit (HI), Kyoto University Hospital, Kyoto, Japan; Graduate School of Pharmaceutical Sciences (IY), Kyoto University, Kyoto, Japan.
² Affiliation of authors: Department of Breast Surgery (MTs, MTo) and Outpatient Oncology Unit (HI), Kyoto University Hospital, Kyoto, Japan; Graduate School of Pharmaceutical Sciences (IY), Kyoto University, Kyoto, Japan. hishimd@kuhp.kyoto-u.ac.jp.

PMID: 24906398
DOI: 10.1093/jnci/dju137

Comment

Re: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment

Moe Tsuda et al. J Natl Cancer Inst. 2014.

. 2014 Jun 6;106(7):dju137.

doi: 10.1093/jnci/dju137. Print 2014 Jul.

Authors

Moe Tsuda¹, Hiroshi Ishiguro², Ikuko Yano¹, Masakazu Toi¹

Affiliations

¹ Affiliation of authors: Department of Breast Surgery (MTs, MTo) and Outpatient Oncology Unit (HI), Kyoto University Hospital, Kyoto, Japan; Graduate School of Pharmaceutical Sciences (IY), Kyoto University, Kyoto, Japan.
² Affiliation of authors: Department of Breast Surgery (MTs, MTo) and Outpatient Oncology Unit (HI), Kyoto University Hospital, Kyoto, Japan; Graduate School of Pharmaceutical Sciences (IY), Kyoto University, Kyoto, Japan. hishimd@kuhp.kyoto-u.ac.jp.

PMID: 24906398
DOI: 10.1093/jnci/dju137

No abstract available

PubMed Disclaimer

Comment in

Response.
Glezerman IG, Hu MI, Jain RK. Glezerman IG, et al. J Natl Cancer Inst. 2014 Jun 6;106(7):dju138. doi: 10.1093/jnci/dju138. Print 2014 Jul. J Natl Cancer Inst. 2014. PMID: 24906399 No abstract available.
RE: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment.
Adhikaree J, Newby Y, Sundar S. Adhikaree J, et al. J Natl Cancer Inst. 2015 Feb 6;107(3):dju509. doi: 10.1093/jnci/dju509. Print 2015 Mar. J Natl Cancer Inst. 2015. PMID: 25663690 No abstract available.

Comment on

Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment.
Hu MI, Glezerman I, Leboulleux S, Insogna K, Gucalp R, Misiorowski W, Yu B, Ying W, Jain RK. Hu MI, et al. J Natl Cancer Inst. 2013 Sep 18;105(18):1417-20. doi: 10.1093/jnci/djt225. Epub 2013 Aug 29. J Natl Cancer Inst. 2013. PMID: 23990665 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Re: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment

Affiliations

Re: Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment

Authors

Affiliations

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical